Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00645164 · ClinicalTrials.gov registry record · Phase 1
Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment
A Phase 1 study of Healthy, sponsored by Healthpoint.
- Completed
- Registry status
- Phase 1
- Development phase
- 59
- Enrollment target
- 1
- Study location
NCT00645164: Completed Phase 1 study of Healthy, sponsored by Healthpoint.
NCT00645164 is a Phase 1 study of Healthy that has completed, run by Healthpoint. The registered enrollment target is 59 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00645164, a Phase 1 study of Healthy, has completed, sponsored by Healthpoint.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
The product is being tested to see if exposure to light causes photoallergic reactions on the skin.
Primary Outcome
Scores based on skin irritation scale of 0 (no reaction) to 7 (large vesiculo-bullous reaction) in whole units. Photoallergic reactions were characterized by irritation scores of 3 or higher.
Conditions Studied
Interventions
- OTHER Ointment Vehicle
- DRUG Xenaderm
Study Locations (1)
North Carolina
- Suncare Research Laboratories - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2008-03 |
| Est. Completion | 2008-06 |
| Phase | Phase 1 |
What the finished NCT00645164 record still lists
NCT00645164 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Ointment Vehicle is the first listed.
NCT00645164 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00645164 about?
NCT00645164 is a clinical study titled "Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment". The product is being tested to see if exposure to light causes photoallergic reactions on the skin.
What is the current status of trial NCT00645164?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 59 participants. The study started on 2008-03. Estimated completion is 2008-06.
What conditions does trial NCT00645164 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT00645164?
The interventions under investigation include: Ointment Vehicle (OTHER), Xenaderm (DRUG).
Who is sponsoring clinical trial NCT00645164?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00645164 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00645164's enrollment target sits among peer trials
59 403rd of 1090 higher than 685 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.
RECRUITING · Phase 1
-
Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants
RECRUITING · Phase 1
-
Comparison of the Short-Term Effect of Dietary Carbohydrate Restriction Versus Exogenous Ketone Supplementation on Myocardial Glucose Suppression and Timing to Achieve a State of Ketosis Using FDG PET/CT Serial Imaging
RECRUITING · Phase 1
-
A Study of V118E in Healthy Participants (V118E-003)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia